L'OXALOSE PRIMAIRE DE TYPE I. MISE AU POINT ET STRATEGIE THERAPEUTIQUE ACTUELLE

Translated title of the contribution: Primary oxalosis type I. Management and present therapeutic strategy

I. Jacques, J. De Ville De Goyet, F. X. Wese, J. B. Otte, G. Cornu

Research output: Contribution to journalArticle

Abstract

Primary oxalosis type I is due to an abnormal metabolism of glyoxylate at the hepatic level responsible of hyperoxaluria. In affected patients, a deposition of calcium oxalate crystals occurs throughout body tissues and the excessive urinary excretion of oxalic acid is the cause of renal and urinary tract lithiasis and nephrocalcinosis leading to renal insufficiency. As soon as the diagnostic has been established (by estimation of blood and urinary levels of oxalate, urinary metabolites and the enzyme activity on a liver biopsy), a medical treatment has to be started. The renal function has to be followed accurately as well as oxalate levels in blood and urine. In the resistant forms of the disease, liver transplantation is the only way to correct the metabolic defect. Renal transplantation may or has to be done at the same time if the renal function is impaired to improve the renal function and to accelerate the removal of oxalate.

Original languageFrench
Pages (from-to)640-651
Number of pages12
JournalLouvain Medical
Volume113
Issue number9
Publication statusPublished - 1994

Fingerprint

Primary Hyperoxaluria
Oxalates
Kidney
Hyperoxaluria
Nephrocalcinosis
Oxalic Acid
Calcium Oxalate
Urolithiasis
Liver
Therapeutics
Urinary Tract
Liver Transplantation
Kidney Transplantation
Renal Insufficiency
Urine
Biopsy
Primary hyperoxaluria type 1
Enzymes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Jacques, I., De Ville De Goyet, J., Wese, F. X., Otte, J. B., & Cornu, G. (1994). L'OXALOSE PRIMAIRE DE TYPE I. MISE AU POINT ET STRATEGIE THERAPEUTIQUE ACTUELLE. Louvain Medical, 113(9), 640-651.

L'OXALOSE PRIMAIRE DE TYPE I. MISE AU POINT ET STRATEGIE THERAPEUTIQUE ACTUELLE. / Jacques, I.; De Ville De Goyet, J.; Wese, F. X.; Otte, J. B.; Cornu, G.

In: Louvain Medical, Vol. 113, No. 9, 1994, p. 640-651.

Research output: Contribution to journalArticle

Jacques, I, De Ville De Goyet, J, Wese, FX, Otte, JB & Cornu, G 1994, 'L'OXALOSE PRIMAIRE DE TYPE I. MISE AU POINT ET STRATEGIE THERAPEUTIQUE ACTUELLE', Louvain Medical, vol. 113, no. 9, pp. 640-651.
Jacques I, De Ville De Goyet J, Wese FX, Otte JB, Cornu G. L'OXALOSE PRIMAIRE DE TYPE I. MISE AU POINT ET STRATEGIE THERAPEUTIQUE ACTUELLE. Louvain Medical. 1994;113(9):640-651.
Jacques, I. ; De Ville De Goyet, J. ; Wese, F. X. ; Otte, J. B. ; Cornu, G. / L'OXALOSE PRIMAIRE DE TYPE I. MISE AU POINT ET STRATEGIE THERAPEUTIQUE ACTUELLE. In: Louvain Medical. 1994 ; Vol. 113, No. 9. pp. 640-651.
@article{61f8386da4b847aa8e7224bec1922c2f,
title = "L'OXALOSE PRIMAIRE DE TYPE I. MISE AU POINT ET STRATEGIE THERAPEUTIQUE ACTUELLE",
abstract = "Primary oxalosis type I is due to an abnormal metabolism of glyoxylate at the hepatic level responsible of hyperoxaluria. In affected patients, a deposition of calcium oxalate crystals occurs throughout body tissues and the excessive urinary excretion of oxalic acid is the cause of renal and urinary tract lithiasis and nephrocalcinosis leading to renal insufficiency. As soon as the diagnostic has been established (by estimation of blood and urinary levels of oxalate, urinary metabolites and the enzyme activity on a liver biopsy), a medical treatment has to be started. The renal function has to be followed accurately as well as oxalate levels in blood and urine. In the resistant forms of the disease, liver transplantation is the only way to correct the metabolic defect. Renal transplantation may or has to be done at the same time if the renal function is impaired to improve the renal function and to accelerate the removal of oxalate.",
author = "I. Jacques and {De Ville De Goyet}, J. and Wese, {F. X.} and Otte, {J. B.} and G. Cornu",
year = "1994",
language = "Francese",
volume = "113",
pages = "640--651",
journal = "Revue medicale de Louvain",
issn = "0024-6956",
publisher = "Louvain Medical asbl",
number = "9",

}

TY - JOUR

T1 - L'OXALOSE PRIMAIRE DE TYPE I. MISE AU POINT ET STRATEGIE THERAPEUTIQUE ACTUELLE

AU - Jacques, I.

AU - De Ville De Goyet, J.

AU - Wese, F. X.

AU - Otte, J. B.

AU - Cornu, G.

PY - 1994

Y1 - 1994

N2 - Primary oxalosis type I is due to an abnormal metabolism of glyoxylate at the hepatic level responsible of hyperoxaluria. In affected patients, a deposition of calcium oxalate crystals occurs throughout body tissues and the excessive urinary excretion of oxalic acid is the cause of renal and urinary tract lithiasis and nephrocalcinosis leading to renal insufficiency. As soon as the diagnostic has been established (by estimation of blood and urinary levels of oxalate, urinary metabolites and the enzyme activity on a liver biopsy), a medical treatment has to be started. The renal function has to be followed accurately as well as oxalate levels in blood and urine. In the resistant forms of the disease, liver transplantation is the only way to correct the metabolic defect. Renal transplantation may or has to be done at the same time if the renal function is impaired to improve the renal function and to accelerate the removal of oxalate.

AB - Primary oxalosis type I is due to an abnormal metabolism of glyoxylate at the hepatic level responsible of hyperoxaluria. In affected patients, a deposition of calcium oxalate crystals occurs throughout body tissues and the excessive urinary excretion of oxalic acid is the cause of renal and urinary tract lithiasis and nephrocalcinosis leading to renal insufficiency. As soon as the diagnostic has been established (by estimation of blood and urinary levels of oxalate, urinary metabolites and the enzyme activity on a liver biopsy), a medical treatment has to be started. The renal function has to be followed accurately as well as oxalate levels in blood and urine. In the resistant forms of the disease, liver transplantation is the only way to correct the metabolic defect. Renal transplantation may or has to be done at the same time if the renal function is impaired to improve the renal function and to accelerate the removal of oxalate.

UR - http://www.scopus.com/inward/record.url?scp=0027944704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027944704&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0027944704

VL - 113

SP - 640

EP - 651

JO - Revue medicale de Louvain

JF - Revue medicale de Louvain

SN - 0024-6956

IS - 9

ER -